Table 1.
Baseline characteristics of enrolled patients (n = 33)
| Characteristic | Number (%) |
|---|---|
| Age (years) | |
| Median | 56 |
| Range | 43–70 |
| Sex | |
| Male | 30 (90.9) |
| Female | 3 (9.1) |
| ECOG performance status | |
| 0 | 22 (66.7) |
| 1 | 11 (33.3) |
| Patient status | |
| Recurrence/metastases after surgery | 10 (30.3) |
| Unresectable tumor with metastases | 23 (69.7) |
| Differentiation | |
| Good | 4 (12.1) |
| Moderate | 13 (39.4) |
| Poor | 14 (42.4) |
| Unknown | 2 (6.1) |
| Number of metastatic sites | |
| 1 | 12 (36.4) |
| 2 | 15 (45.5) |
| ≥3 | 6 (18.2) |
| Site of metastatic disease | |
| Lung | 10 (30.3) |
| Liver | 5 (15.2) |
| Bone | 5 (15.2) |
| Distant lymph nodes | 31 (93.9) |
| Other organ metastases | 2 (6.1) |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.